搜索结果
疾病ID:TCMBANKDI025718
疾病名:Rhabdoid Tumor of the Kidney
MeSH_Name:Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
HPO_Name:-
UMLS_Name:Neoplastic Process
DO_Name:disease of anatomical entity; disease of cellular proliferation
疾病类型:disease
DisGeNET_Link:C0854917
MeSH_Link:C04; C13; C12
HPO_Link:-
UMLS_Link:T191
DO_Link:DOID:7; DOID:14566
HERB_ID:-
疾病对应的植物
| ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
|---|
疾病对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
疾病对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE001111 | KIT | C-Kit; CD117; MASTC; PBT; SCFR | KIT proto-oncogene, receptor tyrosine kinase |
| TCMBANKGE014234 | DLL4 | AOS6; delta4; hdelta2 | delta like canonical Notch ligand 4 |
| TCMBANKGE011280 | USP5 | ISOT | ubiquitin specific peptidase 5 |
| TCMBANKGE000256 | PRKCA | AAG6; PKC-alpha; PKCA; PKCI+/-; PKCalpha; PRKACA | protein kinase C alpha |
| TCMBANKGE014946 | ALK | CD246; NBLST3 | ALK receptor tyrosine kinase |
| TCMBANKGE000567 | CDKN2A | ARF; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4; P16INK4A; P19; P19ARF; TP16 | cyclin dependent kinase inhibitor 2A |
| TCMBANKGE000173 | BRAF | B-RAF1; B-raf; BRAF1; NS7; RAFB1 | B-Raf proto-oncogene, serine/threonine kinase |
| TCMBANKGE001015 | RAC1 | MIG5; MRD48; Rac-1; TC-25; p21-Rac1 | Rac family small GTPase 1 |
| TCMBANKGE013940 | SOAT1 | ACACT; ACAT; ACAT-1; ACAT1; SOAT; STAT | sterol O-acyltransferase 1 |
| TCMBANKGE008180 | PREX1 | P-REX1 | phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 |
| TCMBANKGE000135 | CXCR4 | CD184; D2S201E; FB22; HM89; HSY3RR; LAP-3; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM; WHIMS | C-X-C motif chemokine receptor 4 |
| TCMBANKGE000435 | PROM1 | AC133; CD133; CORD12; MCDR2; MSTP061; PROML1; RP41; STGD4 | prominin 1 |
| TCMBANKGE005068 | SLC12A9 | CCC6; CIP1; WO3.3; hCCC6 | solute carrier family 12 member 9 |
| TCMBANKGE000670 | HDAC8 | CDA07; CDLS5; HD8; HDACL1; KDAC8; MRXS6; RPD3; WTS | histone deacetylase 8 |
| TCMBANKGE000009 | GJA1 | AVSD3; CMDR; CX43; EKVP; EKVP3; GJAL; HLHS1; HSS; ODDD; PPKCA | gap junction protein alpha 1 |
| TCMBANKGE000294 | CDKN1A | CAP20; CDKN1; CIP1; MDA-6; P21; SDI1; WAF1; p21CIP1 | cyclin dependent kinase inhibitor 1A |
| TCMBANKGE000568 | MET | AUTS9; DFNB97; HGFR; RCCP2; c-Met | MET proto-oncogene, receptor tyrosine kinase |
| TCMBANKGE000305 | PIK3CD | APDS; IMD14; P110DELTA; PI3K; p110D | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
| TCMBANKGE011756 | GAB2 | - | GRB2 associated binding protein 2 |
| TCMBANKGE012920 | EPHA3 | EK4; ETK; ETK1; HEK; HEK4; TYRO4 | EPH receptor A3 |
| TCMBANKGE006629 | SPRY2 | IGAN3; hSPRY2 | sprouty RTK signaling antagonist 2 |
| TCMBANKGE000986 | ERBB2 | CD340; HER-2; HER-2/neu; HER2; MLN 19; NEU; NGL; TKR1 | erb-b2 receptor tyrosine kinase 2 |
| TCMBANKGE014353 | ERBB3 | ErbB-3; FERLK; HER3; LCCS2; MDA-BF-1; c-erbB-3; c-erbB3; erbB3-S; p180-ErbB3; p45-sErbB3; p85-sErbB3 | erb-b2 receptor tyrosine kinase 3 |
| TCMBANKGE000078 | BRD4 | CAP; HUNK1; HUNKI; MCAP | bromodomain containing 4 |
| TCMBANKGE000825 | CDKN1B | CDKN4; KIP1; MEN1B; MEN4; P27KIP1 | cyclin dependent kinase inhibitor 1B |
| TCMBANKGE007385 | NRAS | ALPS4; CMNS; N-ras; NCMS; NRAS1; NS6 | NRAS proto-oncogene, GTPase |
| TCMBANKGE009559 | CD99 | HBA71; MIC2; MIC2X; MIC2Y; MSK5X | CD99 molecule (Xg blood group) |
| TCMBANKGE004008 | GRB2 | ASH; EGFRBP-GRB2; Grb3-3; MST084; MSTP084; NCKAP2 | growth factor receptor bound protein 2 |
| TCMBANKGE000307 | PIK3CB | P110BETA; PI3K; PI3KBETA; PIK3C1 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
| TCMBANKGE002052 | CIB1 | CIB; CIBP; KIP1; PRKDCIP; SIP2-28 | calcium and integrin binding 1 |
| TCMBANKGE003195 | PDGFRB | CD140B; IBGC4; IMF1; JTK12; KOGS; PDGFR; PDGFR-1; PDGFR1; PENTT | platelet derived growth factor receptor beta |
| TCMBANKGE000677 | LRP5 | BMND1; EVR1; EVR4; HBM; LR3; LRP-5; LRP-7; LRP7; OPPG; OPS; OPTA1; PCLD4; VBCH2 | LDL receptor related protein 5 |
| TCMBANKGE001199 | PDGFRA | CD140A; PDGFR-2; PDGFR2 | platelet derived growth factor receptor alpha |
| TCMBANKGE000437 | FZD1 | - | frizzled class receptor 1 |
| TCMBANKGE001170 | CDK4 | CMM3; PSK-J3 | cyclin dependent kinase 4 |
| TCMBANKGE001011 | TNFSF10 | APO2L; Apo-2L; CD253; TL2; TNLG6A; TRAIL | TNF superfamily member 10 |
| TCMBANKGE008102 | FZD5 | C2orf31; HFZ5 | frizzled class receptor 5 |
| TCMBANKGE000445 | CD44 | CDW44; CSPG8; ECMR-III; HCELL; HUTCH-I; IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1 | CD44 molecule (Indian blood group) |
| TCMBANKGE000866 | PRKCB | PKC-beta; PKCB; PKCI(2); PKCbeta; PRKCB1; PRKCB2 | protein kinase C beta |
| TCMBANKGE009874 | CDKN2B | CDK4I; INK4B; MTS2; P15; TP15; p15INK4b | cyclin dependent kinase inhibitor 2B |
| TCMBANKGE002172 | COPB2 | MCPH19; beta'-COP | COPI coat complex subunit beta 2 |
| TCMBANKGE005128 | LRIG2 | LIG-2; LIG2; UFS2 | leucine rich repeats and immunoglobulin like domains 2 |
| TCMBANKGE001056 | KRAS | C-K-RAS; C-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; K-Ras; K-Ras 2; KI-RAS; KRAS1; KRAS2; NS; NS3; OES; RALD; RASK2; c-Ki-ras; c-Ki-ras2 | KRAS proto-oncogene, GTPase |
| TCMBANKGE000646 | DECR1 | DECR; NADPH; SDR18C1 | 2,4-dienoyl-CoA reductase 1 |
| TCMBANKGE001060 | YAP1 | COB1; YAP; YAP2; YAP65; YKI | Yes1 associated transcriptional regulator |
| TCMBANKGE000186 | IGF2 | C11orf43; GRDF; IGF-II; PP9974 | insulin like growth factor 2 |
| TCMBANKGE007547 | BRD2 | BRD2-IT1; D6S113E; FSH; FSRG1; NAT; O27.1.1; RING3; RNF3 | bromodomain containing 2 |
| TCMBANKGE000774 | PRRT2 | BFIC2; BFIS2; DSPB3; DYT10; EKD1; FICCA; ICCA; IFITMD1; PKC | proline rich transmembrane protein 2 |
| TCMBANKGE000306 | PIK3CG | PI3CG; PI3K; PI3Kgamma; PIK3; p110gamma; p120-PI3K | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
| TCMBANKGE000295 | FOXO3 | AF6q21; FKHRL1; FKHRL1P2; FOXO2; FOXO3A | forkhead box O3 |
| TCMBANKGE001663 | LRRC4 | NAG14; NGL-2 | leucine rich repeat containing 4 |
滇IICP备16009434号-1 |
Dai SX Lab